https://doi.org/10.4081/itjm.2009.19
Paraneoplastic endocrine-metabolic syndromes
Submitted: 29 April 2013
Accepted: 29 April 2013
Published: 30 April 2013
Accepted: 29 April 2013
Abstract Views: 1242
PDF: 10451
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
AIM OF THE STUDY Here we will focus on the most common PS: paraneoplastic hypercalcemia, inappropriate secretion of antidiuretic hormone (SIADH) and paraneoplastic Cushing syndrome.
CONCLUSIONS Our work can be useful in the diagnosis and therapeutic management of paraneoplastic syndromes.
How to Cite
Grandi, M., Sacchetti, C., Pederzoli, S., Torri, C., Sgarbi, I., Partesotti, G., Nicolini, M., Casarini, C., Romagnani, E., Benatti, C., Vecchi, F., Gollini, C., Manni, B., Sirotti, G., Leone, M. E., Pasqualini, R., & Pedrazzi, A. (2013). Paraneoplastic endocrine-metabolic syndromes. Italian Journal of Medicine, 3(1), 19–29. https://doi.org/10.4081/itjm.2009.19
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
